This study investigates pancreatic ductal adenocarcinoma. It looks at how dietary patterns and the fecal microbiome might relate to chemotherapy response.
The study evaluates how different diets and the diversity of gut bacteria are linked to treatment outcomes. It focuses on understanding these relationships without detailing specific study procedures.
- Who can participate: Adults aged 18 and older with pancreatic ductal adenocarcinoma that is resectable or borderline resectable can participate. Patients must not have advanced or metastatic cancer and should not have started chemotherapy.
- Study details: Participants will complete a dietary survey and provide a fecal sample. The study will compare these to understand their connection to chemotherapy response.
How understandable was the trial content above?
Hard to understand
Easy to understand